Tuesday, February 26, 2013
Dedicated Phase I in Phoenix, Ariz., named a new chief medical officer to head its 80-bed phase I clinical research facility. Clark Springgate, M.D., Ph.D., brings more than 25 years’ experience to the organization, having directed and participated in more than 256 clinical trials, including first-in-man and first-in-therapeutic-class studies.
West Coast Clinical Trials (WCCT) appointed J. Jon Rojas vice president, clinical operations, for the Cypress, Calif.-based early stage CRO. Rojas will provide management oversight and strategic direction of the phase I business unit. Prior to joining WCCT, Rojas served as senior vice president of clinical services and support at OmniComm.